SPH SHANGHAI ZHONGXI PHARMA CO LTD FDA Approval ANDA 211247

ANDA 211247

SPH SHANGHAI ZHONGXI PHARMA CO LTD

FDA Drug Application

Application #211247

Application Sponsors

ANDA 211247SPH SHANGHAI ZHONGXI PHARMA CO LTD

Marketing Status

None (Tentative Approval)001

FDA Submissions

UNKNOWN; ORIG1TA2020-06-11STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

SPH SHANGHAI ZHONGXI PHARMA CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 211247
            [companyName] => SPH SHANGHAI ZHONGXI PHARMA CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"ESLICARBAZEPINE ACETATE","activeIngredients":"ESLICARBAZEPINE ACETATE","strength":"UNKNOWN","dosageForm":"UNKNOWN","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/11\/2020","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-11
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.